LBPH - Longboard Pharmaceuticals Inc Market Value

The share price retrospective for Longboard Pharmaceuticals (LBPH) reflects the dynamics of a company that fully outsources production and testing to third-party contractors, creating a high dependency on partners. The current metric stands at 2.07. The project is currently developing a network of epilepsy treatments, raising capital amid FDA approvals. The business specializes in creating high-precision molecules for the therapy of rare brain pathologies.

Longboard Pharmaceuticals, Inc. - LBPH Market Value (period 07/04/2022 - 12/07/2024)

LBPH (Longboard): analytical breakdowns and indicator data

- current price and projected stock value:

Stock Price Longboard Pharmaceuticals, Inc.|LBPH - Price Target Chart

- market capitalization statistics:

Market Value Longboard|LBPH - Full Business Value

- book value of equity indicators:

Book Value per Share Longboard Pharmaceuticals|LBPH - Accounting Value of Company|Market Value to Book Value Ratio longboardpharma.com|LBPH - Total Business Assets

- debt burden and liquidity indicators:

Total Debt to Capital Longboard Pharmaceuticals|LBPH - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Longboard Pharmaceuticals|LBPH - Company Aggregate Debts|Debt to Book Capitalization Ratio Longboard|LBPH - Company Long-Term Loans and Borrowings|Company Short-Term Debt Longboard Pharmaceuticals|Quick Liquidity longboardpharma.com

- financial results and valuation multiples details:

LBPH - Company Net Income|Expected Profit Longboard Pharmaceuticals|LBPH - Market Cap to Earnings|Future Price to Earnings Longboard Pharma|LBPH - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Longboard|LBPH - Operating profit before depreciation charges|Net earnings per share (EPS TTM) Longboard Pharmaceuticals|LBPH - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months longboardpharma.com|LBPH - Earnings per share growth rate in current year|Earnings growth forecast for next year Longboard Pharmaceuticals

Fundamental company analysis:LBPH (Longboard Pharmaceuticals, Inc.)

The assessment of the financial stability of Longboard Pharmaceuticals begins with an analysis of its market scale. This indicator is calculated as the product of the current share price and the total number of issued securities. The dynamics of the company's market value reflect current capital inflows and market confidence in the asset. For Longboard Pharmaceuticals (LBPH), the capitalization confirms the investment attractiveness of implementing AI and bioanalysis automation. The growth of this metric signals success in accelerating the development of drugs for neuropsychiatric disorders.

Key competitors